Professional Documents
Culture Documents
PRODUCT INFORMATION
F E B R U A R Y 2017
R E V I SE D T A R G E T V A L U ES I N C A L I B R A T O R S /C O N T R O L S
CLINICAL CHEMISTRY
Product, Lot REF Analyt New Rev. New Target Value (Range)
D98481 Dialab reagents – all instruments:
table:
Diacon N, Lot 0811501 D14481 CK-NAC 133 (106 – 160) U/L
08
D98481SV 2.22 (1.77 – 2.66) µkat/L
D98482 Dialab reagents – all instruments:
table:
Diacon P, Lot 0821501 D14482 CK-NAC 424 (339 – 509) U/L
06
D98482SV 7.07 (5.65 – 8.48) µkat/L
D98481 Dialab reagents – all instruments:
table:
Diacon N, Lot 0811601 D14481 CK-NAC 186 (149 – 223) U/L
05
D98481SV 3.10 (2.48 – 3.72) µkat/L
D98482 Dialab reagents – all instruments:
table:
Diacon P, Lot 0821601 D14482 CK-NAC 284 (227 – 341) U/L
05
D98482SV 4.73 (3.79 – 5.68) µkat/L
R E V I SE D P A C K A G E I N S E R T S
CLINICAL CHEMISTRY
Product REF New Rev. Modification
D96596B/D03111B/
D95595/D00616/
D00617/D00618/ Manual test procedure: blank
Creatinine, mod. Jaffe D66911/D0422917
07
Deletion of Glomerular Filtration Rate
DA0823/DB0922
DK0722/DT1023
397750B/397756B/
397758/397759/
300760/396754/ Additional information on interference
Alpha Amylase, CNP-G3 355911/D0405917/ 08
Hazard labelling
3A0805/3T1005/
3K0704/3B0905
D98485 table:
Diacal Auto, Lot 0851701 No values for Bile Acids and Copper
D98485SV 01
D98481 Value table contains only values for Dialab reagents.
table:
Diacon N, Lot 0811701 D14481 System related values for competitor reagents are
01
D98481SV available on request.
D98482 Value table contains only values for Dialab reagents.
table:
Diacon P, Lot 0821701 D14482 System related values for competitor reagents are
01
D98482SV available on request.
1/3
PRODUCT INFORMATION
F E B R U A R Y 2017
IMMUNOTURBIDIMETRY
New
Product REF Modification
Rev.
APO B A00508 03 General revision
A06608H/A06848H/
AA1006/AT1306/
APO B 5+1 AK1306/AK09503/
04 General revision
A0708911H
D-Dimer 913700 02 New filling volumes
ELISA
New
Product REF Modification
Rev.
Cortisol K00201 12 Improved specificity
2/3
PRODUCT INFORMATION
F E B R U A R Y 2017
R E V I SE D S A F E T Y D A T A S H E E TS
New
Product Group Product REF Modification
Rev.
D96596B/D03111B/
D95595/D00616/ Changes in Section 2 (Hazards
Creatinine, mod. Jaffe, D00617/D00618/ identification), 14 (Transport
Clinical Chemistry D66911/D0422917 06
R1 information), 15 (Regulatory
DA0823/DB0922
information); General revision
DK0722/DT1023
D96596B/D03111B/ Changes in Section 8 (Exposure
D95595/D00616/
controls/personal protection), 14
Creatinine, mod. Jaffe, D00617/D00618/
Clinical Chemistry D66911/D0422917 06 (Transport information), 15
R2
DA0823/DB0922 (Regulatory information); General
DK0722/DT1023 revision
397750B/397756B/
397758/397759/ Changes in Section 2 (Hazards
300760/396754/ identification), 3 (Composition /
Clinical Chemistry Alpha Amylase, CNP-G3 355911/D0405917/
04
information on ingredients); General
3A0805/3T1005/
revision
3K0704/3B0905
102300B/1031006B/ Change in Section 14 (Transport
102002/102012/
information):
Bilirubin Direct, 113022/103200
Clinical Chemistry 103210/116320 04 UN3264 CORROSIVE LIQUID, ACIDIC,
Jendrassik Grof, R1
INORGANIC, N.O.S. (HYDROCHLORIC
ACID MIXTURE)
102200B/103107B/ Change in Section 14 (Transport
102001/102011/
information):
Bilirubin Total, 116021/103200/
Clinical Chemistry 103210/116320 06 UN3264 CORROSIVE LIQUID, ACIDIC,
Jendrassik Grof, R1
INORGANIC, N.O.S. (HYDROCHLORIC
ACID MIXTURE)
Please contact us or visit our website for revised safety data sheets and product inserts.
3/3